Newtyn Management LLC Sells 95,000 Shares of Teleflex Incorporated $TFX

Newtyn Management LLC lowered its stake in Teleflex Incorporated (NYSE:TFX) by 23.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 305,000 shares of the medical technology company’s stock after selling 95,000 shares during the period. Teleflex accounts for 4.9% of Newtyn Management LLC’s holdings, making the stock its 7th biggest position. Newtyn Management LLC’s holdings in Teleflex were worth $38,662,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. BlackRock Inc. purchased a new stake in shares of Teleflex during the second quarter valued at $688,537,000. Jupiter Topco LLC purchased a new position in Teleflex in the 2nd quarter worth $550,456,000. AQR Capital Management LLC raised its stake in Teleflex by 478.1% in the 3rd quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after acquiring an additional 1,956,811 shares during the last quarter. Irenic Capital Management LP acquired a new stake in Teleflex during the 1st quarter worth about $104,061,000. Finally, Pzena Investment Management LLC acquired a new stake in Teleflex during the 2nd quarter worth about $76,462,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Price Performance

NYSE:TFX opened at $139.81 on Monday. The firm’s fifty day moving average is $133.86 and its two-hundred day moving average is $126.05. The firm has a market cap of $5.92 billion, a price-to-earnings ratio of -6.00, a PEG ratio of 0.93 and a beta of 0.81. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.12 and a current ratio of 2.60. Teleflex Incorporated has a one year low of $100.18 and a one year high of $145.00.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, August 6th. The medical technology company reported $1.76 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.48. The business had revenue of $570.33 million during the quarter, compared to analyst estimates of $559.59 million. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.The company’s revenue was up 28.9% on a year-over-year basis. During the same quarter last year, the business posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. Research analysts expect that Teleflex Incorporated will post 7.26 EPS for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Friday, August 14th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.0%. The ex-dividend date is Friday, August 14th. Teleflex’s dividend payout ratio (DPR) is currently -5.84%.

Analyst Ratings Changes

TFX has been the topic of a number of research reports. Raymond James Financial reissued an “outperform” rating and issued a $150.00 price objective on shares of Teleflex in a report on Friday, May 8th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Teleflex in a report on Wednesday, June 24th. Needham & Company LLC upped their target price on Teleflex from $159.00 to $170.00 and gave the company a “buy” rating in a research report on Tuesday, August 25th. BMO Capital Markets started coverage on shares of Teleflex in a report on Wednesday, July 8th. They issued an “outperform” rating and a $159.00 price target on the stock. Finally, Piper Sandler reissued an “overweight” rating and set a $169.00 price target (up from $160.00) on shares of Teleflex in a research report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Teleflex has a consensus rating of “Hold” and an average target price of $152.90.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.